Novartis Hopes To Breathe New Life Into CAR-T Business With ASCO Myeloma Data

 
• By Alaric DeArment
  
Novartis and Gilead's Kite Pharma at ASCO • Source: Alaric DeArment
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from ASCO

More from Conferences